Transparency in Europe: A Quantitative Study

In recent years, European pharmaceutical regulators have increasingly committed to heightening access to raw safety‐related data as part of a wave of transparency initiatives (e.g., providing public Internet‐mediated access to clinical trials data). Yet, the regulators—who are under significant pres...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Risk analysis 2015-07, Vol.35 (7), p.1210-1229
Hauptverfasser:	Bouder, Frederic, Way, Dominic, Löfstedt, Ragnar, Evensen, Darrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Awareness Cross-national decisionmaking Drug Industry Economic behaviour Environmental policy Europe Great Britain Health Health risk assessment Manycountries Patient Safety Patients Pharmaceutical industry Pharmaceutical Preparations pharmaceuticals Policies Public Opinion Quantitative analysis Recommendations Regulators Regulatory agencies Risk analysis Risk communication Risk theory Studies Transparency
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!